INTRODUCTION {#S1}
============

Adult stem cells are integral components of normal tissue homeostasis, and their dysfunctions can contribute to human disease ([@R15]; [@R17]; [@R48]). To balance proliferation and differentiation, adult stem cells often reside in dedicated microenvironments called niches, which are cellular complexes composed of tissue-restricted stem cells interacting with neighboring cells ([@R16]; [@R20]; [@R21]). Although much is known about the cellular identities of stem cell niche components, the principles governing their differentiation from specified precursors into three-dimensional (3D) environments in adult tissues remain unclear. Understanding these principles will be important for tissue regeneration strategies that use *in vivo* and *ex vivo* platforms for engineering cellular transplants ([@R4]; [@R23]; [@R31]).

In the adult rodent brain, the lateral ventricular (LV) neurogenic region supports continuous new neuron production throughout life ([@R7]; [@R27]). This subependymal zone (SEZ) and/or subventricular zone (SVZ) niche containing adult neural stem cells (NSCs) is constructed within the first 2 weeks after birth from embryonically specified radial glial progenitors ([@R32]) and serves as an excellent model system to study mechanisms regulating adult stem cell niche assembly. For the SEZ niche, differentiation of at least 2 types of postnatal radial glial progenitors (pRGPs) is required for its functional assembly at the LV surface: (1) pRGPs that retain proliferative capacity to become future adult NSCs ([@R14]) and (2) pRGPs that differentiate into neighboring niche ependymal cells (ECs) ([@R32]; [@R42]). Although little is known about the steps governing transition of pRGPs into adult GFAP^+^ SEZ NSCs, differentiation of niche ECs from pRGPs requires timely and coordinated activation of numerous transcription factors, including Mcidas, Myb, and Foxj1 ([@R41]). This transcriptional cascade results in EC morphological specialization, including basal body duplication and multiciliogenesis ([@R43]). Proper EC differentiation is critical assembling SEZ niches and sustaining adult neurogenesis ([@R32]), as well as preventing hydrocephalus ([@R2]; [@R12]; [@R44]).

The cerebrospinal fluid (CSF), containing various signaling molecules and growth factors during development ([@R11]), contacts the apical membranes of both pRGP populations during postnatal SEZ niche development. Because extracellular environments are temporally and contextually similar for pRGPs destined to becoming adult NSCs and niche ECs, it has generally been assumed that cell-intrinsic programs differentially drive the differentiation of pRGP subpopulations during SEZ niche development. Given the comparable local microenvironments along the LV wall, it remains unclear how specified niche EC progenitors initiate their differentiation while acting on similar extracellular cues as adult NSC progenitors. Although embryonically specified progenitors mature postnatally into adult SEZ niche ECs and NSCs ([@R29]; [@R34]), EC progenitor differentiation can be specifically tracked and readily studied via Foxj1 expression ([@R32]), unlike postnatal NSC progenitors, which at present cannot be easily identified. Using a chemical screen to uncover signaling pathways controlling pRGP differentiation into SEZ niche ECs, we uncovered a previously unknown cellular mechanism for neighboring radial glial progenitors to differentially act on the same extracellular cues, enabling distinct downstream programs in EC progenitors for assembling the adult LV neurogenic niche.

RESULTS AND DISCUSSION {#S2}
======================

EGF Signaling Inhibits pRGP Differentiation into SEZ Niche ECs {#S3}
--------------------------------------------------------------

To interrogate molecular signals controlling the initiation of SEZ niche EC differentiation, we first grew postnatal day 0 (P0) LV progenitors using our established EC culture assay. We showed previously that this culture can efficiently differentiate into ECs following a reduction of media serum concentration from 10% to 2% ([@R32]). We wondered whether reducing certain factors within the serum is necessary to initiate niche EC differentiation from specified pRGPs. To test this, we used chemical inhibitors of fibroblast growth factor (FGF), epidermal growth factor (EGF), platelet-derived growth factor (PDGF), or transforming growth factor β (TGF-β) pathways in EC cultures incubated in 10% serum and screened for their potential to initiate EC differentiation. Although FGF, PDGF, and TGF-β pathway inhibitors showed no significant effects, we found that epidermal growth factor receptor (EGFR)-specific inhibitor (Erlotinib) enabled Foxj1^+^ EC differentiation from pRGPs while incubated in 10% serum ([Figures 1A](#F1){ref-type="fig"}--[1D](#F1){ref-type="fig"} and [S1A](#SD1){ref-type="supplementary-material"}). To confirm that EGFR activity can directly block the initiation of niche EC differentiation, upon initiating EC differentiation in 2% serum, we added EGF to the culturing media. This effectively prevented EC Foxj1 expression and multiciliogenesis ([Figures 1B](#F1){ref-type="fig"}--[1E](#F1){ref-type="fig"}). Chemical inhibition of MEK1/2 (signaling effector kinases downstream of activated EGFR) was also sufficient to initiate Foxj1 expression and EC differentiation under 10% serum condition ([Figures S1A](#SD1){ref-type="supplementary-material"} and [S1B](#SD1){ref-type="supplementary-material"}). Immunohistochemical (IHC) staining for phospho-EGFR (pEGFR, the Y1068-activated form of the receptor) on differentiating EC cultures with the addition of EGF showed strong cellular enrichment compared with controls ([Figure S1C](#SD1){ref-type="supplementary-material"}). Cultures harvested from P0 *FOXJ1-GFP* reporter mice ([@R30]) showed a lack of GFP expression following EGF addition during EC differentiation (compared with robust GFP upregulation in control condition), suggesting lack of *foxj1* transcriptional activation instead of protein stability ([@R2]) ([Figure S1C](#SD1){ref-type="supplementary-material"}).

To evaluate EGF's strong effects on inhibiting niche EC differentiation from pRGPs, we performed transcriptome analyses on differentiating EC cultures in low serum with or without EGF addition. Microarray analyses showed that expression levels of \~3,200 genes were altered when comparing EGF-treated with untreated conditions ([Figure 1F](#F1){ref-type="fig"}). Gene Ontology (GO) analysis identified the main biological process difference as being related to motile cilium assembly, with the top five terms including cilium organization, assembly, movement, and multicilia formation ([Figures 1G](#F1){ref-type="fig"}--[1I](#F1){ref-type="fig"}, [S1D](#SD1){ref-type="supplementary-material"}, and [S1E](#SD1){ref-type="supplementary-material"}). Key factors known to be required for multiciliated cell differentiation ([@R8]; [@R28]), including Mcidas, Gemc1, Myb, and Foxj1, were repressed by the addition of EGF to the culturing media ([Figure S1F](#SD1){ref-type="supplementary-material"}). Additional downstream genes, such as DNAH6, DNAH9, Kif9, and Kif27 ([@R9]), were uniformly downregulated by at least 5-fold ([Figure S1G](#SD1){ref-type="supplementary-material"}). STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) protein-network analyses diagramming gene associations within our dataset specifically indicated EGF's strong effects on attenuating the initiation of EC differentiation from pRGPs ([Figure S1H](#SD1){ref-type="supplementary-material"}). Although the upstream control of multiciliogenesis transcriptional regulator *Foxj1* remains poorly understood, these results suggest that reduced MEK activation in EC progenitors may induce *Foxj1* expression, resulting in multiciliogenesis initiation. However, it remains possible that downregulation of MEK activity directly control aspects of multiciliogenesis gene induction.

EGFR Localization and Downregulation during Postnatal Ependymal Niche Development {#S4}
---------------------------------------------------------------------------------

Our ependymal culture results suggested that terminating developmental EGF signaling after birth is required for initiating niche EC differentiation from pRGPs. Because EGF is known to be present in the CSF contacting the apical surfaces of differentiating ECs ([@R10]; [@R13]), we next wondered whether EGFR expression may be dynamically regulated during this important developmental time window. To track pRGPs fated to become niche ECs, we imaged *FOXJ1-GFP*-expressing cells along the LV neurogenic niche in P1, P3, P7, and P10 animals. Although *FOXJ1-GFP* can mislabel some neural progenitors postnatally ([@R2]; [@R30]), it remains a highly efficient reporter for ECs during their differentiation. At P1, LV germinal matrix GFP^+^ cells retained a radial glial-like morphology with smaller apical surface areas and single basal processes ([Figure S2A](#SD1){ref-type="supplementary-material"}). By P3, these GFP^+^ cells showed apical surface expansion while retaining their basal processes ([Figure S2A](#SD1){ref-type="supplementary-material"}). This apical surface expansion continued during EC differentiation at P7 and P10, with concurrent disappearance of basal processes from GFP^+^ cells ([Figure S2A](#SD1){ref-type="supplementary-material"}). Using orthogonal imaging of GFP^+^ cells on the x-z plane, at P1 we found EGFR expression in GFP^+^ pRGPs at their apical domain, as well as intracellularly ([Figure 2A](#F2){ref-type="fig"}). By P3, EGFR was mostly intracellular, with decreased apical surface expression, while some cells began to show EGFR enrichment at their basolateral membranes ([Figure 2A](#F2){ref-type="fig"}). At P7, we observed EGFR concentrating at the lateral domains of differentiating GFP^+^ ECs, which became mainly basolateral by P10 ([Figure 2A](#F2){ref-type="fig"}). Quantifications of the apically to laterally localized EGFR ratio confirmed redistribution during postnatal EC maturation ([Figure 2B](#F2){ref-type="fig"}). To quantify EGFR redistribution in ependymal pRGPs, we turned to super-resolution stimulated emission depletion (STED) microscopy ([@R24]). We detected distinct EGFR^+^ vesicular particles on the apical and lateral membrane domains of developing P1 FOXJ1-GFP^+^ progenitors ([Figure 2C](#F2){ref-type="fig"}). Using Imaris 3D reconstructing of STED microscopic images and volumetric analysis of EGFR apical density, we were able to calculate the average numbers of EGFR particles per GFP^+^ cell at the apical domain in P1 and P7 animals, showing a significant reduction in the total numbers of apical EGFR particles from P1 to P7 ([Figures 2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}).

To determine whether this postnatal downregulation of EGFR from EC progenitors corresponded to receptor signaling activity, we performed IHC staining for activated pEGFR on LV whole mounts from P3 and P7 *FOXJ1-GFP* animals. Consistently, although we detected pEGFR signals on the apical domains of GFP^+^ pRGPs at P3, they were absent by P7 ([Figure S2B](#SD1){ref-type="supplementary-material"}). The presence of nearby pEGFR^+^ (but GFP-negative) cells within the developing neurogenic niche at P7 suggested that differentiating ECs were able to terminate their EGFR activity within a microenvironment that is activating EGFR in other cell types ([Figure S2B](#SD1){ref-type="supplementary-material"}). In the P35 mature SEZ niche, tamoxifen induction of *nestion-CreER*^*tm4*^*; R26R-tdTomato; FOXJ1-GFP* animals at P14 labels both niche ECs and NSCs ([Figure S2C](#SD1){ref-type="supplementary-material"}). Although as expected we readily detected EGFR IHC staining in tdTomato^+^ SEZ niche astrocytes at P35, we did not find EGFR expression in neighboring GFP^+^ niche ECs ([Figure S2C](#SD1){ref-type="supplementary-material"}).

Because the dynamic redistribution of EGFR from apical to basolateral cellular domains during EC development had not been described previously, we next wanted to examine whether this is functionally required for EC differentiation. We used a well-characterized EGFR mutation, located within the juxtamembrane domain (EGFR-P667A), resulting in receptor misaccumulation at the cellular apical domains, in addition to basolateral targeting ([@R19]). We generated hemagglutinin (HA)-tagged wild type (WT)-EGFR and P667A-EGFR lentiviral constructs, and injected them into P1 animal LVs. To minimize overexpression of EGFR, we limited *in vivo* viral infection to 1%--5% of differentiating pRGPs. IHC staining of LV whole mounts 3 days after injection confirmed that pRGPs can efficiently express WT-EGFR-HA and P667A-EGFR-HA constructs ([Figures S2D](#SD1){ref-type="supplementary-material"} and [S2E](#SD1){ref-type="supplementary-material"}). While WT-EGFR-HA was redistributed temporally from apical to lateral domains similar to endogenously expressed EGFR ([Figures S2D](#SD1){ref-type="supplementary-material"} and [S2F](#SD1){ref-type="supplementary-material"}), P667A-EGFR-HA was retained apically concurrent with a block in pRGP transition to EC morphology ([Figures S2E](#SD1){ref-type="supplementary-material"} and [S2F](#SD1){ref-type="supplementary-material"}). We next performed LV lentiviral injections in P1 *FOXJ1-GFP*^+^ mice. IHC staining of P14 LV whole mounts readily showed control WT-EGFR-HA construct expression in GFP^+^ ECs ([Figure S3A](#SD1){ref-type="supplementary-material"}). Foxj1 and acetylated tubulin antibody IHC co-staining confirmed that WT-EGFR-HA-expressing cells were able to properly differentiate into ECs ([Figures 2F](#F2){ref-type="fig"}--[2H](#F2){ref-type="fig"} and [S3B](#SD1){ref-type="supplementary-material"}). Although most control WT-EGFR-HA expression co-localized with ECs, we also detected as expected its expression in neighboring SEZ astrocytes from targeting P1 pRGPs ([Figures S3A](#SD1){ref-type="supplementary-material"}). In contrast to controls, most mutant P667A-EGFR-HA protein expression co-localized with GFAP^+^ SEZ astrocytes ([Figures 2F](#F2){ref-type="fig"} and [S3C](#SD1){ref-type="supplementary-material"}). It was difficult to detect P667A-EGFR-HA expression in GFP^+^ Foxj1^+^-multiciliated cells ([Figures 2F](#F2){ref-type="fig"}--[2H](#F2){ref-type="fig"}, [S3A](#SD1){ref-type="supplementary-material"}, and [S3B](#SD1){ref-type="supplementary-material"}). Quantifications of control and mutant EGFR construct expressions in Foxj1^+^/multiciliated cells over multiple experiments revealed significant reductions of their cellular co-localization with the mutant receptor ([Figures 2G](#F2){ref-type="fig"} and [2H](#F2){ref-type="fig"}), consistent with our earlier *in vitro* data showing that persistent EGFR activation can effectively block pRGP differentiation into niche ECs. Furthermore, our results showed that instead of simply regulating receptor expression, selective protein redistribution is a key step in terminating EGFR activation and allowing postnatal niche EC differentiation to proceed.

EGFR Activation Defects in Numb/Numblike Mutant Ependymal Niche Progenitors {#S5}
---------------------------------------------------------------------------

We next wondered which molecular mechanisms control EGFR redistribution in pRGP to downregulate extracellular growth factor signaling. The endocytic adaptor protein Numb was first identified as a key mediator of cellular asymmetric division ([@R35]; [@R36]; [@R49]). Subsequent experiments have shown that Numb can interact with plasma membrane receptors to control their recycling and degradation ([@R18]). At P1, Numb IHC staining on LV whole mounts from *FOXJ1-GFP* reporter animals showed strong intracellular distribution in GFP^+^ ependymal pRGPs ([Figure 3A](#F3){ref-type="fig"}). Between P3 to P7, Numb became localized to lateral cellular domains in GFP^+^ cells during niche EC differentiation ([Figure 3A](#F3){ref-type="fig"}). STED super-resolution imaging of differentiating EC pRGPs showed EGFR and Numb co-localizing to vesicular structures ([Figures 3B](#F3){ref-type="fig"}, [3C](#F3){ref-type="fig"}, and [S4A](#SD1){ref-type="supplementary-material"}). At P1, there was robust EGFR and Numb co-localization at apical and basolateral domains, which became more basolateral by P7 ([Figures 3B](#F3){ref-type="fig"}, [3C](#F3){ref-type="fig"}, and [S4A](#SD1){ref-type="supplementary-material"}). Upregulation of Numb protein in FOXJ1-GFP^+^ pRGPs consistently coincided with EGFR expression ([Figure S4B](#SD1){ref-type="supplementary-material"}).

To determine whether this Numb protein redistribution was responsible for EGFR trafficking, we deleted Numb and its closely related homolog Numblike (Nbl) in EC progenitors by inter-crossing *FOXJ1-Cre; Numb*^F/+^*; Nbl*^KO/+^ and *Numb*^F/+^*; Nbl*^KO/+^ animals to generate *FOXJ1-Cre; Numb*^F/+^*; Nbl*^KO/KO^ (control) and *FOXJ1-Cre; Numb*^F/F^*; Nbl*^KO/KO^ (conditional double knockout \[cDKO\]) mice. The *CAG-GFP* Cre-dependent reporter line was also crossed into the genetic background to label *FOXJ1-Cre*-targeted cells. Numb cDKO mice developed significant ventriculomegaly, glial scaring, and reduced multicilia coverage on the LV wall postnatally ([Figures S4B](#SD1){ref-type="supplementary-material"}--[S4G](#SD1){ref-type="supplementary-material"}) and did not survive past 5 weeks of age. IHC staining of P14 control versus cDKO ventricular sections showed that although, as expected, we did not detect EGFR expression in GFP^+^ ECs in control samples, there was strong EGFR expression in GFP^+^ cells in cDKO samples ([Figure 3D](#F3){ref-type="fig"}). Furthermore, IHC staining of P14 LV whole mounts detected aberrant pEGFR on the apical membrane of cDKO mutant cells ([Figure 3E](#F3){ref-type="fig"}). LV whole-mount western blot analyses comparing P14 control and cDKO animals showed that although total AKT and ERK1/2 protein levels were equivalent, pAKT, pERK1/2, and pEGFR levels (activated forms) were all significantly increased in cDKO samples ([Figure 3F](#F3){ref-type="fig"}), confirming abnormal EGFR activation. Quantifications of GFP^+^ cells comparing P10 cDKO with control LV whole mounts showed cDKO cells had significantly increased GLAST expression and reduced apical surface diameter, indicative of pRGP to EC maturation defects ([Figures S4F](#SD1){ref-type="supplementary-material"} and [S4G](#SD1){ref-type="supplementary-material"}). There was phenotypic variability in cDKO GFP^+^ cells postnatally, and we believe this is caused by our timing of conditional *Numb* deletion and Numb protein perdurance. Using onset of *foxj1* gene transcription to express Cre for *Numb* deletion also initiates the Foxj1-driven multiciliogenesis program in Cre-targeted cells. Ideally, one would need an EC progenitor-specific Cre driver that turns on postnatally before Foxj1-initiated multiciliogenesis, but to our knowledge such a driver line has not been identified.

Endocytic Adaptor Protein Numb Regulates EGFR Trafficking in Ependymal Progenitors {#S6}
----------------------------------------------------------------------------------

To examine potential biochemical interactions between Numb and EGFR, we first preformed immunoprecipitation (IP) experiments using tagged protein expression constructs. Co-transfections of HA-EGFR and Numb-GFP into HEK293 cells, followed by protein lysate IP with anti-GFP antibody, resulted in a robust pull-down of HA-EGFR ([Figure 4A](#F4){ref-type="fig"}). As a control, co-transfections of HA-EGFR and GFP followed by anti-GFP IP did not pull down HA-EGFR ([Figure 4A](#F4){ref-type="fig"}). IP experiments on acutely isolated P3 LV whole mounts showed efficient co-precipitation of EGFR and Numb proteins ([Figure 4B](#F4){ref-type="fig"}). EGFR is internalized and recycled from the plasma membrane in a clathrin-dependent manner through activity of AP-2 protein containing complexes ([@R47]). Numb has been shown to interact with AP-2 and clathrin-coated pits via α-adaptin protein ([@R6]). Moreover, Numb becomes decoupled from the recycling endocytic machinery following Ca^2+^-dependent phosphorylation at serine 276 (S276) by calmodulin-dependent protein kinase (CaMK), inhibiting its interactions with AP-2 and clathrin-mediated endocytosis ([@R40]; [@R45], [@R46]). Thus, EGFR may be interacting with Numb at the apical membrane, internalized, and recycled, where Numb S276 phosphorylation at the basolateral membrane accumulates EGFR/Numb by decoupling from the endocytic machinery. Western blot analyses of postnatal LV wall samples revealed that S276 phospho-Numb (pNumb) levels increased from nearly undetectable levels at P1 to high expression by P7, while there was only modest increase in total Numb protein concurrently ([Figure 4C](#F4){ref-type="fig"}), consistent with temporal dynamics of Numb lateralization in ependymal progenitors ([Figure 3A](#F3){ref-type="fig"}).

Although it remains unclear which signaling cascades are at the basolateral membranes during ependymal niche maturation that resulted in increased Numb accumulation instead of continued endocytic recycling, we reasoned that constitutive S276 phosphorylation will prevent Numb from recycling EGFR from the apical membrane through the normal endocytic pathway. To test whether Numb directly regulates trafficking of EGFR, we generated a phosphomimetic version of Numb converting S276 to aspartic acid (S276D), which would continuously inhibit its interaction with the endocytic AP-2 protein complex. IP experiment showed that similar to WT-Numb-GFP, S276D-Numb-GFP mutant protein can physically interact with EGFR ([Figure 4A](#F4){ref-type="fig"}). To confirm protein expression and localization, we first expressed WT-Numb-GFP or S276D-Numb-GFP in Madin-Darby canine kidney (MDCK) cells. While as expected WT-Numb-GFP protein was basolaterally localized, the S276D-Numb-GFP mutant protein also showed significant apical membrane localization ([Figure 4D](#F4){ref-type="fig"}). We next injected lentiviral constructs expressing WT-Numb-GFP or S276D-Numb-GFP proteins into the LVs of P1 animals and stained LV whole mounts for EGFR and GFP expression at P7. We found that EGFR was dramatically upregulated in S276D-Numb-GFP-expressing cells with EGFR localized both apically and intracellularly, in contrast to control WT-Numb-GFP-expressing cells with mainly basolateral EGFR ([Figure 4E](#F4){ref-type="fig"}). We observed considerable co-localization between EGFR and S276D-Numb-GFP both apically and intracellularly ([Figure 4E](#F4){ref-type="fig"}). Together with the genetic mutant phenotype described earlier, these results demonstrated that Numb critically controls EGFR localization during EC differentiation, thereby downregulating their EGF-mediated cellular activation.

Despite its functional importance in sustaining the proliferative capacity of adult NSCs in health and disease, principles governing postnatal construction of the LV neurogenic niche from pRGPs remain poorly understood. Here we show a previously undescribed cellular pathway for postnatal development of the LV ependymal niche. EGFR signaling plays important roles in the expansion and migration of neuroprogenitors during development, but it was unclear how neighboring pRGPs along the LV surface switch from proliferation to a differentiation program postnatally during SEZ niche assembly. While we did not observe obvious EGFR localization changes in Foxj1-negative pRGPs during this early postnatal period, we found that Foxj1^+^ EC progenitors accomplished timely suppression of EGFR activity through a receptor trafficking step from their apical to basolateral membrane domains, away from ligand-induced activation. This cellular program enabled EC progenitors to efficiently switch from proliferation to differentiation, without waiting for receptor turnover, while the microenvironment continues to support EGF-mediated neurogenic proliferation.

Mechanistically, we identified physical interactions between EGFR and endocytic adaptor protein Numb. Originally described in *Drosophila* as a critical regulator of progenitor asymmetric cell division, mammalian Numb and Nbl also play important roles during neural development ([@R26]; [@R33]; [@R38]). Numb has been shown to biochemically interact with clathrin-coated vesicles, AP-2, and EHD/RME-1 proteins via aspargine-proline-phenylalanine (NPF) and aspartate-proline-phenylalanine (DPF) interaction motifs ([@R37]; [@R39]). These protein-protein interactions between the plasma membrane and the intracellular endocytic compartments enable Numb to recycle TrkB receptors at the leading edge of migrating neuroblasts ([@R53]), as well as metabotropic glutamate receptor 1 in Purkinje cells ([@R54]). While we uncovered Numb/EGFR interactions in ependymal pRGPs, it is likely that Numb has cargos beside EGFR in ependymal pRGPs during postnatal development.

What are the possible upstream signals triggering Numb trafficking of EGFR from the apical membrane of ependymal pRGPs? In epithelial cells, Numb is targeted basolaterally and recycles from endocytic to plasma membrane domains via Ca^2+^-dependent signaling ([@R40]). Here we show highly specific Numb basolateral trafficking in pRGPs during EC development, temporally and functionally important for EGFR targeting and downregulation of its activity. While a conserved function for Numb in mammalian asymmetric cell division during neural development remains debated, it is exciting that Numb's endocytic trafficking function in this context allowed differential engagement of a key environmental stimulus between neighboring pRGPs. Because we observed increased Numb phosphorylation at the CaMK-dependent S276 site postnatally, and because CaMK is activated by increased cytosolic \[Ca^2+^\] ([@R50]), these results predict that increased intracellular \[Ca^2+^\] is a likely initiator of Numb basolateral localization developmentally. It is unknown whether increased \[Ca^2+^\] in pRGPs originates from extracellular sources or intracellular stores, and future research in these areas should illuminate cellular principles controlling adult stem cell niche assembly from progenitors.

STAR★METHODS {#S7}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S8}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Chay T. Kuo (<Chay.kuo@duke.edu>). Plasmids generated in this study will be deposited to Addgene.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S9}
--------------------------------------

### Knockout and transgenic mice {#S10}

Mice were housed (up to 5 animals per cage) in a controlled with 12 h/12 h light/dark cycle at Duke University. Mice were fed a standard chow diet and provided *ad libitum* access to food and water throughout the study. All mouse experiments were performed according to an approved protocol by the Institutional Animal Care and Use Committee at Duke University. Both male and female mice were used throughout the study. No significant effect of sex was observed during analysis. Age of animals used is described in figure legends. The following mouse lines were used: *FOXJ1-GFP* ([@R30]); *nestin-CreER*^*tm4*^ ([@R25]); *FOXJ1-Cre* ([@R51]); *numb*^*flox/+*^ ([@R52]); *numblike*^*KO/+*^ ([@R33]); *CAG-EGFP* reporter ([@R22]); *R26R-tdTomato* ([@R3]).

### Primary ependymal cultures {#S11}

Primary ependymal cultures were generated from postnatal radial glial progenitors harvested from P0-P1 neonatal mouse pups as previously described ([@R2]). Briefly, lateral ventricular walls were dissected, triturated in growth media (DMEM-High Glucose4.5 g/L (GIBCO)/DMEM-F12 1:1 mixture, 10% FBS (Hyclone), and 1% Pen/Strep) and plated in 24 well plates coated with Poly-D-Lysine (Sigma), then incubated under normal cell culture conditions in growth media. After cell culture reached 90%--100% confluence (\~3--4 days after plating), media were switched and kept in differentiation media conditions (DMEM-High Glucose 4.5 g/L (GIBCO), 2% FBS (Hyclone), 1% L-glutamine, and 1% Pen/Strep 2% FBS).

### Cell lines {#S12}

293T17 and MDCK cell lines were acquired from ATCC and were cultured according to their recommended conditions (see [Key Resources Table](#T1){ref-type="table"}).

METHOD DETAILS {#S13}
--------------

### Staining of primary ependymal cultures {#S14}

ECs were grown from primary postnatal radial glial progenitors harvested from P0-P1 neonatal mouse pups as previously described ([@R2]). EGF (20 ng/ml, Invitrogen) was added to 2% serum differentiation media for the treatment condition. For immunofluorescence staining, cell cultures were grown on 12 mm glass coverslips coated with Poly-D-Lysine, washed once in PBS, fixed in either 2% or 4% paraformaldehyde solution. Fixed cells were permeabilized in PBS containing 0.1% Triton X-100 (PBST), and blocked using 10% donkey serum in PBST. Primary antibody solutions were incubated overnight at 4°C, and conjugated secondary antibodies were incubated for 3 hours at 4°C. DAPI was incubated for 20 minutes at room temperature.

### Immunohistochemistry and imaging {#S15}

IHC of brain coronal sections and lateral ventricular wall wholemounts were prepared as previously described ([@R2]). Briefly, samples fixed directly in paraformaldehyde solution (4% or 2%) followed by permeabilization in 0.1% PBST solution. Donkey serum at 10% in PBST was used to block tissue sections and wholemounts prior to immunolabeling. Confocal images were acquired on Leica TCS SP5 confocal microscope, with control and experimental samples imaged under identical settings. Super-resolution images were acquired using a Leica DMi8 motorized inverted microscope with STED and confocal capability. Deconvolution was carried out using the Huygens deconvolution software. Primary antibodies solutions were incubated overnight at 4°C with tissue, and fluorescently conjugated secondary antibodies were incubated for 2 hours at room temperature. All antibodies are listed in the [Key Resources Table](#T1){ref-type="table"}.

### Biochemistry and immunoprecipitation {#S16}

Cell cultures or tissue samples were lysed and prepared for immunoblotting as previously described ([@R1]). Lysates were resolved on Tris-Glycine SDS-PAGE gels (Bio-rad) and transferred onto PVDF membranes (Bio-rad). Antibodies were diluted in PBS containing 0.1% Triton X-100 with 2% BSA, followed by overnight incubation at 4°C. Detection was accomplished through secondary antibodies conjugated to horseradish peroxidase (Cell Signaling) and treated with enhanced chemiluminescence. HEK293 cells were grown on 24-well culture dishes. 24 hours after plating, HEK293 cells were transfected with equal amounts of plasmids for WT-Numb-GFP, S276D-Numb-GFP, and WT-EGFR-HA. 24 hours after transfection, media was replaced with low serum media then harvested 24 hours later. Immunoprecipitations were performed on HEK293 cells lysed in buffer containing 0.02 M HEPES Buffer, 0.15 M NaCl, 1% Triton X-100, sodium orthovanadate (Sigma), protease inhibitor cocktail (Roche), 10 mM NaF. Supernatants were collected from lysates spun at 15K rpm for 20 minutes, and primary antibodies incubated either 4 hours at room temperature or overnight at 4°C. Secondary antibodies conjugated to agarose beads were incubated for 2 hours at room temperature. Beads were washed 5 times in lysis buffer, harvested in 5X PAGE, processed for SDS-PAGE analysis and western blotting. All antibodies are listed in the [Key Resources Table](#T1){ref-type="table"}.

### Transcriptome analyses {#S17}

Affymetrix Gene Chip microarray data underwent strict quality control processing using the simpleaffy package in the Bioconductor2 suite from the R statistical programming environment. Log-scale Robust Multiarray Analysis (RMA) from the affy package was used to normalize the data and eliminate systematic differences across the arrays. Differential expression of genes across the conditions was identified from a moderated test statistic employed by the limma package. The False Discovery Rate (FDR) method was used to correct for multiple hypothesis testing. Gene set enrichment analysis was performed to identify differentially regulated pathways and gene ontology terms for each of the comparisons performed. Heatmap of the differentially expressed genes (FDR ≤ 0.05) for each \< Ctrl \> versus \< EGF \> comparison. Gene expression has been z-score normalized and the samples and genes are clustered by correlation distance with complete linkage. The heatmap shows all genes that were identified as significant in at least one of the comparisons. Heatmaps only include genes that had an FDR ≤ 0.05 and a log2FC \> 5 or \< −5. Hierarchical clustering plot of all of the samples based on expression of all genes on the arrays were shown. The samples are clustered using a correlation distance with complete linkage. Samples are colored by their condition.

### Quantitative PCR {#S18}

Total RNA was extracted using RNA easy mini Kit (QIAGEN), followed by cDNA preparation using Superscript Vilo cDNA synthesis kit (Invitrogen). Quantitative PCR analyses were performed using SYBR Green as previously described ([@R2]). All primers are listed in [Table S1](#SD1){ref-type="supplementary-material"}.

### DNA constructs and lentiviral preparation {#S19}

The WT-Numb-GFP, cloned into peGFP plasmid, was a gift from Jane McGlade ([@R40]). The S276D mutation was generated in WT-EGFR-GFP using site directed mutagenesis (Q5, New England Biosciences), sequenced to confirm no additional mutations were generated. WT-Numb-GFP and S276D-Numb-GFP were cloned into PWXLD plasmid to generate lentiviruses. The EGFR-HA construct contains a c-terminal 3x-HA tag and was cloned into pEGFP by replacing the EGFP cassette. WT-EGFR-HA and P667A-EGFR-HA were cloned into PWXLD plasmid to generate lentiviruses. Lentiviruses were produced in 293T17 cells through triple-transfection of transfer plasmids pWPXLD, psPAX2, and pMD2.G. Lentivirus-containing media was collected, filtered through 0.45 micron membranes. To concentrate lentiviruses, media was spun for 2 hours at 25K rpm using swinging bucket rotor in Beckman Coulter ultracentrifuge. Numb and EGFR mutagenesis was performed by site-directed mutagenesis using the New England Biolabs Q5 site directed mutagenesis system according to the manufacturer's instructions. All DNAs sequenced to verify that only the desired mutations were present.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S20}
---------------------------------------

No statistical methods were used to pre-determine samples sizes, but they are similar to those reported elsewhere ([@R5]; [@R25]; [@R32]). For representative images and western blots, the results were shown to be reproducible by at least five separate experiments. Blocking of experimental design was assigned by animal genotype and was not randomized. Depending on sample size, unpaired Student's t test (≥R10) or Wilcoxon two-sample test (≥R5) were used for statistical comparisons between two datasets. One-way ANOVA was used to compare more than two datasets. Graphs are presented as mean ± SEM and *P value*s are presented in the figure legends. Statistical significance was set at a *P value* \< 0.05.
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![EGF Inhibition of Ependymal Differentiation\
(A) IHC images of EC cultures grown in differentiation media (Serum^low^), media containing 10% serum (Serum^high^), or media containing both 10% serum and Erlotinib (Serum^high^ + Erl.). Samples were labeled with antibodies to Foxj1, acetylated tubulin (a-Tub), and DAPI. Scale bar: 20 µm.\
(B) IHC images of EC cultures grown in differentiation media or differentiation media + EGF (EGF) and labeled with antibodies to Foxj1, a-Tub, and DAPI. Scale bar: 20 µm.\
(C) Quantifications of Foxj1^+^ cells as the percentage of total DAPI-labeled cells. \*p \< 0.0001, one-way ANOVA; \*\*p \< 0.0064, Wilcoxon two-sample test; n = 5; mean ± SEM.\
(D) Quantifications of multiciliated cells (visualized by a-Tub staining) as the percentage of total DAPI-labeled cells. \*p \< 0.0001, one-way ANOVA; \*\*p \< 0.0064, Wilcoxon two-sample test; n = 5; mean ± SEM.\
(E) Western blot analysis of EC cultures grown in differentiation media (Serum^low^), 10% serum (Serum^high^), or 10% serum + Erlotinib (Serum^high^ + Erl.). Actin is the loading control.\
(F) Transcriptome heatmap, with genes changing at least 2-fold between EGF-treated (EGF) and untreated (Ctrl) cultures. Log~2~ expression values were row normalized using *Z* scores and clustered using hierarchical clustering.\
(G--I) Enriched GO terms (G) ranked by the percentage of genes located in each library. The number of genes identified for biological process (H) and cell compartment (I) is indicated for each bar graph.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1538148-f0002){#F1}

![Apical to Basolateral Ependymal EGFR Localization\
(A) IHC images in x-z views of LV whole mounts from *FOXJ1-GFP*^+^ animals, with antibodies to EGFR, GFP, and DAPI. Scale bar: 10 µm.\
(B) Quantification of the apical/basolateral EGFR expression ratio in *FOXJ1-GFP*^+^ pRGPs. \*p \< 0.0001, one-way ANOVA, n = 10 cells for each group, mean ± SEM.\
(C) STED super-resolution images from the P1 and P7 LV surface labeled with EGFR and GFP antibodies. Single apical and lateral optical sections are shown. Scale bar: 5 µm.\
(D) 3D rendering of STED super-resolution images from (C), with EGFR in red and GFP in white for clarity. Scale bars: 2 µm.\
(E) Quantifications of apical EGFR particles as the fraction of the volume measured. \*p \< 0.001, Student's t test, n = 10, mean ± SEM.\
(F) IHC images from P14 LV whole mounts injected P1 with either WT-EGFR-HA or P667A-EGFR-HA lentivirus and labeled with anti-Foxj1/HA antibodies and DAPI. The asterisk indicates the cell body of HA^+^ cells quantified; note apically expressed P667A-EGFR-HA (arrow, left panels) from the deeper section of the same cell in right panels (\*). Scale bars: 10 µm.\
(G) Quantifications of Foxj1^+^ cells per total HA^+^ cells for each construct. \*p \< 0.0286, Wilcoxon two-sample test, n = 4 animals, mean ± SEM.\
(H) Quantifications of multicilia^+^ cells per total HA^+^ cells for each construct. \*p \< 0.0286, Wilcoxon two-sample test, n = 4 animals, mean ± SEM.\
See also [Figures S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"}.](nihms-1538148-f0003){#F2}

![EGFR Activation Defects in Numb/Numblike Mutants\
(A) IHC images of LV whole mounts from *FOXJ1-GFP*^+^ mice labeled with antibodies to Numb/GFP and DAPI. At P1, most GFP^+^ cells strongly expressed Numb (arrows), while GFP-dim cells showed lower Numb levels (\*). Scale bar: 10 µm.\
(B) STED super-resolution images of LV whole mounts from P1 *FOXJ1-GFP*^+^ animals labeled with antibodies to Numb, EGFR, and DAPI. AP, apical domain; BL, basolateral domain. x-z view, optical section from longest x-y axis. Scale bar: 5 µm.\
(C) Quantifications of Numb/EGFR co-localization at AP or BL domains from P1 (top graph) or P7 (bottom graph) animals. Co-localization, average Pearson's coefficient. \*p \< 0.03, \*\*p \< 0.0001, Student's t test, n = 12 cells, mean ± SEM.\
(D) IHC images of LV neurogenic niche coronal sections from P14 control (Ctrl) or *FOXJ1-Cre; Nb*^flox/flox^*; Nbl*^KO/KO^*; CAG-GFP* (cDKO) animals labeled with antibodies to GFP and EGFR. Note the cDKO GFP^+^ cells with high-level EGFR and AP localization (arrows).\
(E) IHC images of LV whole mounts from P14 Ctrl or cDKO animals, labeled with antibodies to pEGFR and GLAST and showing mutant cells strongly expressing pEGFR (dashed circles). Scale bar: 20 µm.\
(F) Western blot analysis of LV whole mounts from P14 Ctrl or cDKO animals. Actin is the loading control.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1538148-f0004){#F3}

![EGFR Trafficking via Numb Phosphorylation\
(A) IP from HEK293 cell lysates co-transfected with constructs as indicated (+) and probed with antibodies to HA (EGFR, upper blot) and GFP (Numb, lower blot).\
(B) IP from P3 LV whole mounts using anti-Numb or anti-EGFR antibodies. Blots were then probed with anti-Numb and anti-EGFR antibodies.\
(C) Western blot analyses of LV walls of indicated ages and blotted for Numb and pNumb276. Actin is the loading control.\
(D) IHC images of MDCK cells expressing either WT-Numb-GFP or S276D-Numb-GFP stained with anti-GFP antibody and DAPI. Single optical section views are from cellular apical surfaces (apical view, top row) or below the surface showing lateral membrane domains (lateral view, bottom row). Scale bars: 10 mm. The ratio of GFP fluorescent intensity at apical versus lateral domains for WT-Numb-GFP and S276D-Numb-GFP is shown. \*p \< 0.001, Student's t test, n = 10, mean ± SEM.\
(E) IHC images of P7 LV whole mounts expressing WT-Numb-GFP or S276D-Numb-GFP (from P1 lentiviral infection) labeled with anti-GFP, EGFR antibodies, and DAPI. Note high-level EGFR expression in S276D-Numb-GFP-expressing cells, but not WT-Numb-GFP-expressing cells (\*). Right panels: single optical plane of the apical membrane, with enlarged areas showing high-level EGFR localization with S276D-Numb-GFP (dashed boxes). Scale bars: 10 µm; inset 1 µm.\
(F) Schematic illustrations showing EGFR/Numb localizations during postnatal ependymal maturation (top) and the putative molecular pathway of EGFR redistribution (bottom).](nihms-1538148-f0005){#F4}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                            SOURCE                IDENTIFIER
  -------------------------------------------------------------- --------------------- --------------------------------------
  Antibodies                                                                           
  Mouse monoclonal anti-Acetylated-tubulin                       Sigma                 Cat\#- T7451; RRID:AB_609894
  Rabbit polyclonal anti-Foxj1                                   Sigma                 Cat\#- HPA005714; RRID:AB_1078902
  Mouse monoclonal anti-GLAST                                    Miltenyi Biotech      Cat\#- 130-095-822; RRID:AB_10829302
  Mouse monoclonal anti-HA-tag                                   Genescript            Cat\#- A01244-100; RRID:AB_1289306
  Chicken polyclonal anti-HA-tag                                 Aves                  Cat\#- ET-HA100; RRID:AB_2313511
  Rabbit polyclonal anti-EGFR                                    Genetex               Cat\#- GTX100448; RRID:AB_1950176
  Rabbit polyclonal anti-pEGFR                                   Abcam                 Cat\#- ab5644; RRID:AB_305012
  Rabbit polyclonal anti-AKT                                     Cell Signaling        Cat\#- 4691T; RRID:AB_915783
  Rabbit polyclonal anti-pAKT                                    Cell Signaling        Cat\#- 4060T; RRID:AB_2315049
  Rabbit polyclonal anti-ERK                                     Cell Signaling        Cat\#- 9102S; RRID:AB_330744
  Rabbit polyclonal anti-pERK                                    Cell Signaling        Cat\#- 9101S; RRID:AB_331646
  Goat polyclonal anti-Numb                                      Abcam                 Cat\#- ab4147; RRID:AB_304320
  Rabbit polyclonal anti-Notch                                   Cell Signaling        Cat\#- 4147S; RRID:AB_2153348
  Mouse monoclonal anti-S100b                                    Sigma                 Cat\#- SAB1402349; RRID:AB_10640343
  Chicken polyclonal anti-GFP chicken                            Aves                  Cat\#- GFP1020; RRID:AB_10000240
  Chicken polyclonal anti-GFAP                                   Aves                  Cat\#- GFAP; RRID:AB_2313547
  Mouse monoclonal anti-GFAP                                     Sigma                 Cat\#- G3893; RRID:AB_477010
  Rabbit polyclonal anti-γ-Tubulin                               Sigma                 Cat\#- T5192; RRID:AB_261690
  Bacterial and Virus Strains                                                          
  Lentivirus WT-Numb-GFP                                         This paper            N/A
  Lentivirus S276S-Numb-GFP                                      This paper            N/A
  Lentivirus WT-EGFR-HA                                          This paper            N/A
  Lentivirus P67A-EGFR-HA                                        This paper            N/A
  Chemicals, Peptides, and Recombinant Proteins                                        
  Erlotinib                                                      Selleckchem           S7786
  Mek Inhibitor                                                  Selleckchem           S1036
  EGF                                                            Invitrogen            PHG0311
  Critical Commercial Assays                                                           
  Q5 site directed mutagenesis kit                               New England Biolabs   E0554S
  Superscript Vilo cDNA synthesis kit                            Invitrogen            11754050
  Deposited Data                                                                       
  Ependymal microarray data                                      This paper            GEO: GSE124518
  Experimental Models: Cell Lines                                                      
  293T17                                                         ATCC                  CRL-11268
  MDCK                                                           ATCC                  PTA-6500
  Experimental Models: Organisms/Strains                                               
  *FOXJ1-GFP*                                                    [@R30]                N/A
  *nestin-CreER*^*tm4*^                                          [@R25]                N/A
  *FOXJ1-Cre*                                                    [@R51]                N/A
  *numblike*^*KO/+*^                                             [@R33]                N/A
  *CAG-EGFP*                                                     [@R22]                N/A
  *numb*^*flox/+*^                                               [@R52]                N/A
  *R26R-tdTomato*                                                [@R3]                 N/A
  Oligonucleotides                                                                     
  Refer to [Table S1](#SD1){ref-type="supplementary-material"}                         N/A
  Recombinant DNA                                                                      
  PWPXLD-WT-Numb-GFP                                             This paper            N/A
  PWPXLD-S276D-Numb-GFP                                          This paper            N/A
  PWPXLD-WT-EGFR-HA                                              This paper            N/A
  PWPXLD-P667-EGFR-HA                                            This paper            N/A

###### Highlights

-   EGFR downregulation promotes postnatal radial glial differentiation into ependyma

-   Apical EGFR redistributes to ependymal basolateral domains, limiting its activation

-   Endocytic adaptor Numb traffics ependymal EGFR during adult neurogenic niche assembly

-   Progenitors differentially act on the same extracellular cues via receptor redistribution
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